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We report the analysis of 335 microsatellite markers genotyped in 110 multiplex families with autism. All families
include at least two “affected” siblings, at least one of whom has autism; the remaining affected sibs carry diagnoses
of either Asperger syndrome or pervasive developmental disorder. Affected sib-pair analysis yielded multipoint
maximum LOD scores (MLS) that reach the accepted threshold for suggestive linkage on chromosomes 5, X, and
19. Nominal evidence for linkage (point-wise ) was obtained on chromosomes 2, 3, 4, 8, 10, 11, 12, 15,P ! .05
16, 18, and 20, and secondary loci were found on chromosomes 5 and 19. Analysis of families sharing alleles at
the putative X chromosomal linked locus and one or more other putative linked loci produced an MLS of 3.56
for the DXS470-D19S174 marker combination. In an effort to increase power to detect linkage, scan statistics were
used to evaluate the significance of peak LOD scores based on statistical evidence at adjacent marker loci. This
analysis yielded impressive evidence for linkage to autism and autism-spectrum disorders with significant genome-
wide P values !.05 for markers on chromosomes 5 and 8 and with suggestive linkage evidence for a marker on
chromosome 19.
Introduction
Autism [MIM 209850] is a neuropsychiatric disorder
characterized by severe social and communicative defi-
cits, together with a pattern of restricted or repetitive
behaviors or interests. Developmental abnormalities as-
sociated with autism typically manifest in the first 3 years
of life and persist into adulthood. Autism is typically
characterized as part of a spectrum of disorders that
includes Asperger syndrome (AS) and other pervasive
developmental disorders (PDD). AS is distinguished
from autistic disorder by the lack of a clinically signif-
icant delay in language development (phrase use at age
3 years; single words at age 2 years) in the presence
of the impaired social interaction and restricted-repeti-
tive behaviors, interests, and activities that characterize
the autism-spectrum disorders (ASDs). PDD is used to
categorize children who do not meet the strict criteria
for autism but who come close, either by manifesting
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atypical autism or by nearly meeting diagnostic criteria
in two or three of the key areas.
Until fairly recently, autism was considered a rare
disorder with an estimated prevalence of 4–5 patients
per 10,000 individuals. More-recent studies have led to
estimates of 10–12 patients per 10,000 individuals (Gill-
berg and Wing 1999). We do not yet know whether
this difference reflects an increased prevalence of autism,
a gradual change in diagnostic criteria, a recognition of
greater variability of disease expression, or a heightened
awareness of the disorder. The estimated prevalence of
autism plus related spectrum disorders, excluding AS,
is approximately double that of autism alone (Wing and
Gould 1979). It is well documented that autism occurs
three to four times more frequently in males than in
females.
Evidence from twin and family studies clearly estab-
lishes the importance of genetic factors in the devel-
opment of autism and ASDs (Folstein and Rutter 1977;
Bailey et al. 1995). In the largest study to date, 15 (60%)
of 25 monozygotic twins were concordant for autism,
compared with 0 of 20 dizygotic pairs. In the same
study, 190% of monozygotic twins were concordant for
social and cognitive abnormalities that meet criteria for
ASD (Bailey et al. 1995). These data suggest an unu-
sually high degree of heritability for susceptibility to
autism and ASDs; 190% for the latter, when a multi-
factorial threshold model for disease liability is as-
328 Am. J. Hum. Genet. 69:327–340, 2001
sumed. The sibling recurrence risk for autism is esti-
mated to be ∼2%–4% (Jorde et al. 1991; Szatmari et
al. 1998). Thus, when a population prevalence of
0.05%–0.1% is assumed, the estimated relative risk for
autism in a sibling is 45–90 times greater than the pop-
ulation risk. The incidence of autism falls significantly
with decreasing degree of relatedness to an affected in-
dividual, an observation consistent with the involve-
ment of multiple interacting genetic loci. Thus, autism
and related spectrum disorders present as complex ge-
netic disorders and most likely result from the combined
effects of multiple susceptibility alleles in concert with
environmental factors or other nongenetic factors.
Autism appears to be both clinically and genetically
heterogeneous. Approximately 10%–25% of patients
with autism present with other medical disorders, prin-
cipal among which are fragile X syndrome (MIM
309550) (Feinstein and Reiss 1998) and tuberous scle-
rosis (MIM 191100) (Smalley 1998). In addition, case
studies suggest that a small but significant portion of
autism cases are associated with a broad spectrum of
chromosomal abnormalities, most frequent among
which are chromosome 15 structural anomalies (15q11-
q13) (Christian et al. 1999). Interest in this region is
further enhanced by evidence for imprinting among sev-
eral resident genes and by the mapping of Prader-Willi
syndrome (PWS) and Angelman syndrome to this re-
gion. Both disorders are affected by imprinted genes,
and a subset of patients with both PWS and Angelman
syndrome reportedly manifest autismlike symptoms
(Reik and Walter 1998). It has recently been reported
that a disproportionate subset of patients with Turner
syndrome (single X chromosome) develop autismlike
symptoms (Skuse et al. 1997). Among patients with
Turner syndrome, those who inherit a single maternal
X chromosome are apparently at significantly greater
risk of developing autism than are their counterparts
who inherit a paternal chromosome, again suggesting
an imprinting mechanism (Skuse 2000).
Although there are a number of biological and neu-
roanatomical clues that might inform the genetic study
of autism, most findings are not consistent or robust
from study to study, probably because of the hetero-
geneous etiology of the disorder. Among the most con-
sistent findings are reports of higher numbers of plate-
lets and/or higher levels of serotonin in urine in patients
with autism than in control subjects (Anderson et al.
1987). Other studies indicate that serotonin reuptake
inhibitors improve autism symptoms in an as yet un-
defined subset of patients (Brodkin et al. 1997; Fatemi
et al. 1998). Both linkage and association studies appear
to hint at a role for the serotonin transporter gene; how-
ever, the evidence remains unclear (Cook et al. 1997;
Maestrini et al. 1999; Zhong et al. 1999).
Several independent groups have recently reported
full-genome scans in which they used microsatellite
markers to detect linkage to autism or ASDs. The results
of four such studies are summarized in a recent review
article (Lamb et al. 2000). In the first study, which was
conducted by the InternationalMolecular Genetic Study
of Autism Consortium (IMGSAC) (1998), six chro-
mosomal regions were reported to yield maximummul-
tipoint LOD scores 11.0 (chromosomes 4, 7, 10, 16,
19, and 22). The highest positive LOD score resulting
from this analysis was 2.53 on chromosome 7q32-35.
Subsequent investigation of this region with a dense set
of microsatellite markers and 26 additional families in-
creased the multipoint LOD score to 3.63 (Maestrini
and IMGSAC 1999). The Paris Autism Research Inter-
national Sibpair Study (Philippe et al. 1999) reported
hints of linkage (P values !.05) at 11 chromosome
regions, including chromosomes 2, 4, 5, 6, 7, 10, 15,
16, 18, 19, and X. Four chromosomal regions—2q, 7q,
16p, and 19p—appear to overlap with results from the
IMGSAC study. The highest positive LOD score from
this second genome scan was 2.23, on the long arm of
chromosome 6.
A third full-genome scan (Risch et al. 1999) yielded
maximum likelihood scores 11.0 on chromosomes
17p, 7p, and 18q, with a highest genomewide score
of 2.15 on chromosome 1p. The authors build a case
that their data are most consistent with a disease
model specifying 15 loci (Risch et al. 1999). Finally,
the Collaborative Linkage Study of Autism (CLSA)
(Barrett et al. 1999) produced maximum multipoint
heterogeneity LOD scores (MMLS/het) of 3.0 at
D13S100 and 2.3 between markers D13S217 and
D13S1229. The third highest score from this analysis
was 2.2, at D7S1813 (7q), under the recessive model.
In follow-up studies of the chromosome 7 findings,
Buxbaum et al. (1999) and Ashley-Kock et al. (1999)
independently report moderate evidence for linkage
to chromosome 7q, after analyses of sample sets of
60 families and 76 families, respectively.
In the present study, we report the whole-genome
microsatellite marker analysis of 110 multiplex families
affected by autism. We use a battery of 335 microsat-
ellite markers and analyze the data with an affected sib-
pair (ASP) approach and a novel approach that employs
scan statistics.
Families and Methods
Family Recruitment and Diagnostic Assessments
The Cure Autism Now (CAN) Foundation and Hu-
man Biological Data Interchange have created a large
central repository of family DNA samples, known as the
Autism Genetic Resource Exchange (AGRE), for genetic
studies of autism. Families are recruited nationwide
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through advertisement sponsored by the CAN national
support group and by referrals from clinicians. The in-
itial selection criteria require that at least two family
members have a diagnosis of autism or ASD (i.e., autism,
PDD, or AS). Prospective families are then contacted,
and an in-home visit is arranged with a trained diag-
nostician. During these visits, one or both parents are
interviewed regarding the affected children in the family,
using the Autism Diagnostic Interview-Revised (ADI-R)
protocol (Lord et al. 1994). The ADI-R is a scored, semi-
structured interview that is based on the criteria for di-
agnosis of autism described in the International Statis-
tical Classification of Diseases and Related Health
Problems, 10th revision, and the Diagnostic and Statis-
tical Manual of Mental Disorders, 4th ed. Diagnostic
assessments are videotaped and subjected to independent
reliability checks by other trained interviewers. Individ-
uals scored as affected in the current linkage analysis
had to satisfy the prespecified cutoff scores in all three
symptom areas of the ADI-R (social impairment, lan-
guage and communication impairment, and unusual or
restricted interests), as well as have an age at onset of
!3 years. In addition, other pediatric, neurodevelop-
mental, and psychiatric information are being collected
from these families, using a uniform medical examina-
tion, the Autism Diagnostic Observation Scale, as well
as other measures.
In this study we have chosen two phenotypes for ge-
netic analysis; first, a narrow diagnostic category that
includes only autism, and second, a broader category
that includes autism plus AS and PDD. As described in
the report of the IMGSAC study (1998), genetic sus-
ceptibility to autism extends to AS and PDD (Bolton et
al. 1994; Bailey et al. 1995), but the relatively low pop-
ulation prevalence of autism (Bailey et al. 1996) mini-
mizes the likelihood that significant genetic heteroge-
neity will be introduced as a consequence of including
relative pairs with autism plus either AS or PDD.
Laboratory Procedures
Blood was collected from all affected individuals and,
when available, from parents and unaffected siblings.
Blood samples were collected into Vacutainer tubes con-
taining trisodium citrate, citric acid, and dextrose. Lym-
phocytes were immortalized by standard transformation
protocols with Epstein-Barr virus (Anderson andGusella
1984). DNA was extracted from both whole blood and
immortalized lymphoblast cell lines by standard pro-
teinase potassium-digestion and salting-out protocols. A
complete description of each sample is available through
AGRE. PCR amplification of microsatellite markers was
performed as described elsewhere (Aita et al. 1999). In
brief, multiplex PCR was performed in 384-well PCR
plates (Marsh), using PTC 225 thermocyclers (MJ Re-
search) with a total volume of 10 ml containing 50 ng
of genomic DNA, 0.15-0.2 mMMgCl2, 0.2 mM dNTPs,
and 0.5 units of Taq Platinum polymerase (Gibco Life
Tech). On average, each multiplex PCR contains four
microsatellite markers with varying amounts of primer
(1–50 pmol), to achieve roughly even amplification of
each marker. PCR products from two to three multiplex
PCR reactions were pooled and genotyped using ABI
model 377 DNA sequencers. For all markers, the last
nucleotide of the reverse, nonfluorescent primer was
modified to a guanine residue to promote the nontem-
plated addition of adenine byTaqDNApolymerase onto
the complementary, fluorescence-labeled strand. This
method has been reported to consistently shift the allelic
profile of PCR products toward the allele plus and en-
zymatically added adenine residue, which allows for
more accurate allele calling (Magnuson et al. 1996). PCR
products were resolved using the PRISM 377XL data
collection software and were sized by application of the
GENESCAN 2.1 and GENOTYPER v.1.1.1 software
packages (Applied Biosystems). The computer-generated
genotypes were checked by two independent researchers
who were blinded to disease diagnosis. The genotypes
were then imported to the LABMAN genotyping data-
base (Adams 1994), for allele binning andMendelization
checking. CEPH control individuals (1330-1 and 1330-
2) were used to standardize the sizes of PCR products
for each marker.
Genetic Markers
A total of 335 microsatellite markers were used in the
full-genome scan. The majority of markers were selected
from version 8.0 of the Marshfield fluorescence-labeled
genome screening set (Center for Medical Genetics,
Marshfield Medical Research Foundation). The average
heterozygosity of markers used in this study is 0.77.Map
distances (in Kosambi centimorgans) were obtained
from Marshfield (Broman et al. 1998).
Statistical Analysis
Multipoint ASP analysis of genotype data was per-
formed using the MAPMAKER/SIBS program (v2.1)
(Kruglyak and Lander 1995). Allele frequencies were
estimated from the family data, using the PEDMANA-
GER program. The main approach of ASP analysis is
the likelihood-ratio method of Risch (1990a; 1990b),
which maximizes the likelihood of incompletely poly-
morphic genotype data with respect to the probabilities
of sharing zero, one, or two alleles identical by descent
(IBD). Holmans (1993) and Faraway (1993) indepen-
dently suggested restriction of the maximization to the
set of sharing probabilities consistent with possible ge-
netic models, denoted the “possible triangle”; defined by
and , where z1 and z0 are the shar-z  0.5 z  0.5# z1 0 1
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ing of one and zero alleles IBD, respectively. It was
shown that the power of the likelihood-ratio test can be
increased by restricting maximization to this possible
triangle (Holmans 1993; Holmans and Clayton 1995)
Therefore, the present study calculated all maximum
likelihoods by restricting to the possible triangle. We
note that maximized LOD scores (MLS) obtained in this
way are asymptotically distributed as mixtures of x2 dis-
tributions with 1 and 2 df; hence, to obtain the nominal
point-wise threshold of an MLS 1 0.74 is re-P ! .05
quired, where
2P(MLS)p .5# P x 1 2 ln 10#MLS( )1
20.098# P x 1 2 ln 10#MLS( )2
(Holmans 1993; Knapp 1997; Sham 1998; Nyholt
2000). However, evidence—based on an infinitely dense
map—of genomewide suggestive ( ) and4P ! 7.4# 10
significant ( ) linkage (Lander and Krug-5P ! 2.2# 10
lyak 1995) is reached at MLS values of 2.45 and 3.93,
respectively.
Cordell et al. (1995) extended Holmans’ method to
X-linked data, showing it was not appropriate to com-
bine data from brother-brother, sister-sister, and brother-
sister pairs; instead, they introduced an X-MLS statistic,
which considers the three groups separately by restrict-
ing the maximization to the following genetically valid
values: 0  z  0.5, 0  z  0.5, and 0  z 1bb 1ss 1bs
, where z1 represents IBD sharing of maternal alleles.0.5
The sum of these three MLS statistics, termed X-MLS,
is a mixture of x2 distributions with 1, 2, and 3 df (Cor-
dell et al. 1995; Nyholt 2000); hence, to obtain the nom-
inal threshold of , an is required.P ! .05 X-MLS 1 1.18
however, evidence—based on an infinitely dense
map—for suggestive and significant linkage is reached
at X-MLS values of 3.06 and 4.62 respectively, where
2( )P XMLS p0.375# P x 1 2 ln 10#XMLS( )1
20.375# P x 1 2 ln 10#XMLS( )2
20.125# P x 1 2 ln 10#XMLS)( 3
Additionally, we analyzed data for paternal and ma-
ternal contributions to IBD sharing, using the ASPEX
(sib-phase) program (Hauser et al. 1996). We note, how-
ever, that the overall ASPEX results will differ from those
obtained using MAPMAKER/SIBS, as ASPEX uses only
the first sib of an affected pair and all unaffected sibs
for reconstruction of missing parental genotypes, but
MAPMAKER/SIBS uses all inheritance information.
Furthermore, MAPMAKER/SIBS performs complete
multipoint analysis, using all markers across the chro-
mosome, but ASPEX simply finds the nearest informa-
tive markers flanking a particular locus, to help deter-
mine phase (IBD status).
To aid interpretation of the linkage analysis results,
we used simulation to calculate sample-specific empirical
genomewide significance values for our data sets. For
both the broad and narrow data sets, 1,000 replicates
were simulated under the assumption of no linkage, us-
ing the SIMULATE program (Terwilliger and Ott 1994).
Each replicate was analyzed using MAPMAKER/SIBS.
Genomewide significance values were obtained by
counting the number of times an MLS (or equivalent X-
MLS) was reached in the 1,000 replicates.
To increase power for localizing disease loci, we ap-
plied a novel approach that uses scan statistics to eval-
uate the significance of peak LOD scores on the basis
of the LOD scores of the markers surrounding the peak
(Hoh and Ott 2000). This approach is based on the fact
that, in a genome screen, true peaks tend to be wider
than false peaks (Terwilliger et al. 1997). Scan statistics
are currently implemented for dichotomous data. From
the given family observations, dichotomous data were
obtained in the following two ways. (1) Two kinds of
independent sib pairs were created, that is, affected-
affected (AA) and affected-unaffected (AU) pairs, by
pairing offspring 1 with each of the subsequent offspring
in turn. For the broad classification scheme, this resulted
in 86 AA pairs and 91 AU pairs. (2) For undivided fam-
ilies, marker genotypes were generated by computer sim-
ulation, under the assumption of no linkage, such that
observed data can be compared with “null” data. For
the broad classification scheme, this resulted in 108 ob-
served families and 432 computer-generated families.
For each unit (sib-pair or family) of the two types of
dichotomous data, nonparametric LOD scores were
computed at each marker by the ALLEGRO program
(Gudbjartsson et al. 2000). Analyses with scan statistics
were performed only for the broad classification scheme,
because it appeared to provide more linkage information
than a narrow diagnostic scheme. Genomewide empir-
ical levels, , were computed with Monte Carlo per-Pglobal
mutation tests with sample sizes of 20,000 replicates
(Hoh and Ott 2000)
Results
Quality of Genotyping Data
At the onset of this project, the AGRE sample con-
sisted of 132 multiplex families, including 14 families
with identical twins (12 autism:autism twins, 1 autism
:PDD, and 1 autism:AS). Although these families were
excluded from linkage analysis, they provide an internal
control for estimation of genotyping errors. The 28 sam-
ples were configured randomly throughout the micro-
titer plates used for genotyping the entire sample. Re-
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searchers were blind to their identity. Three hundred
thirty-five markers were genotyped against the 28 sam-
ples to yield ∼9,000 genotypes. Direct comparison of
genotypes between identical twins identified seven allelic
mismatches, giving an estimated error rate of 0.0007 (7/
9,000). During the generation of ∼177,000 genotypes
for the entire data set, 157 Mendelian errors were de-
tected and corrected, giving an observed error rate of
0.00089 (157/177,215). Detectable Mendelian errors
are expected to account for the majority of genotyping
errors, although errors that do not violate transmission
laws will certainly go undetected in the small nuclear
families that constitute the majority of our sample.
Statistical Analyses
When we used the broad affection criteria, that is,
autism, AS, or PDD—and after we removed an iden-
tical twin from 14 families—110 of the 132 families
had two or more affected siblings, providing a total
of 118 ASP comparisons. Analogously, our use of the
narrow criteria (that is, strict autism) resulted in 72
families with two or more affected siblings and a total
of 75 ASP comparisons. Of the 110 families, 40 in-
clude one unaffected sibling; 10 families include two,
and 1 family includes four unaffected siblings. One
hundred five families include both parents; the re-
maining five families include one parent. Phenotypic
information is not available for parents. Four families
included three affected sibs, and for the majority (71
families) of the remaining families with two affected
sibs, both sibs are diagnosed with autism.
Results of multipoint ASP analysis of these families
are presented in figure 1. We note that the broad and
narrow data sets are not independent, with the narrow
data set making up ∼64% (75/118) of the broad data
set; however, a suitable correction is not clear. Subse-
quently, the analysis results are presented concurrently
and without correction, to highlight the validity of using
either diagnostic scheme, and their statistical interpre-
tation is left to our readers.
Linkage analysis under the broad-diagnosis scheme
produced MLS peaks with significance below the nom-
inal threshold of on 13 chromosomes (2, 4, 5,P ! .05
8, 10, 11, 12, 15, 16, 18, 19, 20, and X). The region
of greatest significance was on chromosome 5 at marker
D5S2494, which surpassed the recommended genome-
wide threshold for suggestive linkage, producing anMLS
of 2.55 ( ) (Lander and Kruglyak 1995). AnPp .00058
MLS 2.55 was obtained 197 times in the 1,000 sim-
ulated replicates, resulting in an occurrence expectation
(OE) of 0.197 times in a genome scan; that is, we would
expect to get a score of this magnitude once in every
5.08 (1/OE) genome scans. The next-most-significant re-
gion was on chromosome X at marker DXS1047, with
an X-MLS of 2.56 ( ), which also surpassedPp .0023
the suggestive linkage threshold, producing an OE of
0.887. Other regions of interest include peaks near
D5S2488 with an MLS of 1.90 ( ), which hadPp .0028
a borderline suggestive linkage OE of 1.078 at D19S714
( , , and ), D8S1179MLSp 1.72 Pp .0043 O p 1.646E
( , , and ) andMLSp 1.66 Pp .005 O p 1.897E
D16S2619 ( , , andMLSp 1.46 Pp .0081 O pE
); all other loci produced MLS values !1.4 (3.038 P 1
)..01
Linkage analysis under the narrow diagnosis scheme
produced MLS peaks with significance below Pp .05
on seven chromosomes (3, 5, 10, 16, 18, 19, and X).
The region of greatest significance was on chromosome
19, near marker D19S714, which also surpassed the ac-
cepted genomewide threshold for suggestive linkage,
producing an MLS of 2.53 ( and OE pPp .00061
0.325). The next-most-significant region, also reaching
the suggestive linkage threshold, was again on chro-
mosome X at marker DXS1047 with an X-MLS of 2.67
( and ). Other regions of interestPp .0018 O p 0.803E
include peaks near D16S2619 ( ,MLSp 1.93 Pp
, and ), D5S2488 ( ,.0026 O p 1.125 MLSp 1.63E
, and ), D5S2494 ( ,Pp .0054 O p 2.162 MLSp 1.41E
, and ) and a secondary peak onPp .0092 O p 2.504E
chromosome 19, midway between D19S587 and
D19S601 ( , , ); allMLSp 1.70 Pp .0045 O p 1.863E
other loci produced MLS values with .P 1 .01
Examination of the multipoint MLS plots in figure 1
shows high concordance between results obtained using
the broad and narrow diagnostic schemes. However, al-
though some regional peaks differ considerably in size
(∼1 MLS unit)—for example, the peaks at D5S2494,
D8S1179, and D19S714—the MLS pattern is conserved
under both diagnostic schemes, thus indicating that the
differences are due to heterogeneity between the two
data sets and not necessarily to differences between the
broad and narrow autism phenotypes.
Paternal and maternal contributions to increased allele
sharing for loci significant at , in both the broadP ! .05
and narrow data sets, are presented in table 1. Exami-
nation of these contributions shows some striking par-
titioning between parental contributions. In particular,
the majority of IBD sharing at D5S2488 seems to orig-
inate from the paternal side, and the majority of sharing
at D5S2494 (59 cM away) is from the maternal side,
which suggests that two distinct loci may be present on
this chromosome. Similarly, the majority of IBD sharing
at D19S714 is maternally contributed, but the sharing
at D19S587-D19S601 (30 cM away) is paternally con-
tributed, which again suggests the presence of two sep-
arate loci. In any event, the breakdown of parental con-
tributions by sex provides further suggestive evidence
for the role of imprinting in the genetics of autism.
The presence of a strong sex effect was also noted by
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Figure 1 Chromosome-wise results from MAPMAKER/SIBS multipoint ASP analysis. Solid lines represent results based on use of the
narrow diagnosis, and dashed lines represent results based on use of the broad diagnosis.
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Table 1
Summary of Parental Contributions to IBD Sharing in ASPs
CHROMOSOME cM LOCUS
ASPEX MLS OF IBD SHARING IN
Broad ASPs Narrow ASPs
Paternal Maternal Overall Paternal Maternal Overall
5 .0 D5S2488 1.75 .08 1.77 1.02 .46 1.44
5 58.9 D5S2494 .38 .86 1.23 .28 1.07 .79
16 20.0 D16S2619 .78 .66 1.44 .40 1.38 1.76
18 .0 D18S59 .44 .25 .68 .68 .47 1.15
19 32.0 D19S714 .20 .94 1.15 .62 1.25 1.90
19 61.5 D19587-
D18601 .36 .00 .37 1.12 .31 .79
NOTE.—Locus positions are indicated as centimorgan distance from a start point p 0, at pter. ASPs are
categorized according to diagnostic criteria described in Families and Methods. Maternal and paternal
contributions to IBD sharing were obtained using the ASPEX (sib-phase) program, as described in Statistical
Analysis. MLS are depicted for multiplex families partitioned according to the likelihood (!50% vs.50%)
of sharing maternal alleles at DXS1047.
Ashley-Koch et al. (1999). In their study of 62 ASPs and
nine markers spanning 35 cM on chromosome 7q, a
categorization of linkage results according to parental
contribution indicated significant paternal ( ),Pp .007
but not maternal ( ), IBD sharing. Subsequently,Pp .75
given our positive X-chromosome linkage results cou-
pled with the observed paternal/maternal partitioning of
IBD sharing, we decided to further investigate this ap-
parent sex effect by partitioning our data on the basis
of observed allele-sharing on the X chromosome. Spe-
cifically, both the narrowly and broadly characterized
families were separated on the basis of the likelihood
(!50% vs. 50%) of sharing maternal alleles at
DXS1047. The resulting data sets consisted of 39 “X-
linked” and 36 “X-unlinked” narrow ASPs, and 56 “X-
linked” and 62 “X-unlinked” broad ASPs. Linkage re-
sults for these data sets are summarized in table 2.
When linkage analyses are conditioned on sharing at
DXS1047, they provide further evidence for a strong sex
effect in our populations. Of particular note is the ap-
parent interaction between sharing at DXS1047 and
D19S714, with alleles at these loci tending to be ma-
ternally coinherited. Furthermore, the peak at D19S587-
D19S601 is predominantly inherited from the paternal
side in families with no increased sharing at DXS1047.
Similarly, sharing at D1S547 and D7S2195-D7S3058 is
restricted to families not sharing alleles at DXS1047,
and sharing at D16S2619 and D18S59 is concentrated
in families with increased sharing at DXS1047. Our data
clearly hint at some interaction between loci on the X
and autosomal chromosomes that may help to explain
the skewed sex ratio in autism.
Application of scan statistics (Hoh and Ott 2000) to
quasi-independent sib-pair data yielded the results pre-
sented in table 3 (only the broad classification is pre-
sented because the narrow classification shows no in-
teresting results). For each marker, the difference in total
LOD score between AA and AU pairs was computed,
which represented the marker-specific statistic, Xi, for
the i-th marker. Then, sums of such single-marker sta-
tistics for L consecutive markers were formed. The most
significant of these is the scan statistic, SL, for given
length L. Conventional analysis of one marker at a time
(SLp1) revealed D8S1136 on chromosome 8 as the single
best marker, with an associated empirical significance
level of . On the other hand, the best scanP p .131global
statistic consisted of the sum of the marker-specific sta-
tistics for the six contiguous markers surrounding
D8S1136 (i.e., D8S1477-D8S1119). The associated ge-
nomewide significance level was . An allow-Pp .015
ance for multiple testing of various lengths of scan sta-
tistics reduced this significance to . WhenP p .047global
scan statistics were applied to the markers on one chro-
mosome at a time, none of the chromosomes (other than
chromosome 8) showed results significant at the 5%
level. Application of scan statistics to all possible AA
and AU sib-pairs (without different weighting depending
on sibship size) furnished analogous, but nonsignificant,
results.
Although contrasting AA pairs (positive LOD scores
expected with linkage) with AU pairs (negative LOD
scores expected with linkage) is expected to be powerful,
results somewhat depend on the choice of offspring for
the first sibling when quasi-independent sib-pairs are
formed (sib 1 vs. sib 2, sib 1 vs. sib 3, etc.). Therefore,
we also applied scan statistics to entire families, even
though their LOD scores can only be compared with an
expected value of zero for no linkage. The marker-spe-
cific statistic of interest was the LOD score achieved for
the given marker, and sums of these statistics for con-
tiguous markers were calculated as described above. As
noted above, empirical genomewide significance levels,
Pglobal, were estimated through permutation samples
(which generated four times more “null” results than
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Table 3
Scan Statistics SL of Varying Lengths L for
Sib-Pair Data (Broad Diagnosis)
L Varianta SL
b Pc
1 D8S1136 3.50 .131
2 D8S1136 6.91 .050
3 D8S1113 9.69 .034
4 D8S1113 11.85 .030
5 D8S1477 14.27 .021
6d D8S1477 16.42 .015
7 D8S382 17.76 .016
8 D8S382 18.58 .020
9 D8S1145 19.17 .024
10 D8S1106 18.94 .040
NOTE.—ASPs are categorized according
to diagnostic criteria described in Families
and Methods.
a Variant p first element of SL.
b Scan statistics SL of varying lengths L
for sib-pair data resulting in a statistic of
.P p .015min
c Overall significance level is P pglobal
..047
d Best scan statistic.
Table 2
Summary of Linkage Results after Partitioning According to IBD Sharing at DXS1047
CHROMOSOME cM LOCUS
MAPMAKER/SIBS MLS
Broad ASPs Narrow ASPs
!50%  50% !50% 50%
1 251.3 D1S547 2.22 .0 .37 .0
5 .0 D5S2488 .81 1.11 1.02 .77
5 58.9 D5S2494 1.02 1.54 .29 1.28
7 152.8 D1S219-D1S3058 1.21 .0 .56 .13
16 20.0 D16S2619 .08 1.94 .31 2.19
18 .0 D18S59 .10 .81 .20 1.33
19 32.0 D19S714 .07 2.16 .07 3.59
19 61.5 D19587D19601 1.00 .28 1.53 .32
19 73.4 D19S601 1.31 .01 2.52 .0
NOTE.—ASPs are categorized according to diagnostic criteria described in Families and Methods.
did observed data). The strongest result was obtained
for marker D5S2488 ( , which, accordingP p .0104global
to Lander and Kruglyak [1995], corresponds to a max-
imum LOD score of ). Marker D8S1179Z p 4.38max
also showed a significant result with (cor-P p .0162global
responding to ). Finally, suggestive linkageZ p 4.17max
evidence was obtained for D19S714 with P pglobal
(corresponding )..3426 Z p 2.60max
Discussion
Table 4 summarizes linkage findings from the current
and previous whole-genome linkage studies. Among the
five whole-genome scans performed to date, 14 LOD
scores 1.0 have been reported from 10 different chro-
mosomes. Five of the putative linked regions are from
the present study, including three findings on chromo-
somes 5q, 8q, and Xqter that have not been previously
reported. Two of the findings from the present study,
those for chromosomes 16p and 19p, were also identified
in the scans reported elsewhere. Among the three strong-
est findings to emerge from our study (chromosomes 5q,
19q, and Xqter), only the region on chromosome 19q
has previously been implicated in autism linkage studies.
Interpretation of such putative linkage findings is com-
plicated, a point that is well illustrated in the analytical
section of the report by Risch and colleagues (1999).
Given the numerous complications that affect interpre-
tation of complex linkage studies, it is of interest that
data from five genomewide scans and several partial
scans indicate a convergence of evidence for several
regions, among which chromosome 7 appears to be
prominent. A similar convergence of data, implicating a
section of chromosome 10 as harboring a gene for Alz-
heimer disease, was recently reported by three groups
(Bertram et al. 2000; Ertekin-Taner et al. 2000; Myers
et al. 2000).
Given the interest in chromosome 7, we performed a
follow-up analysis of the chromosomal region impli-
cated by previous studies (position 115 to the telomere).
Figure 2 depicts the six microsatellite markers used for
the genome scan, plus 28 additional microsatellite
markers employed in the “dense” follow-up analysis.
The follow-up analysis includes the original 110 families
described in this study, plus an additional 50 AGRE
families of composition very similar to those of the in-
itial collection. As is shown in figure 2, the dense-marker
follow-up analysis reveals a peak LOD score of 1.0 at
position 125 (marker D7S523) and another peak of
2.13 at position 165 (marker D7S483). The peak
around position 125 might be construed as supportive
of studies reported elsewhere, but the second peak at
position 165 appears to be novel.
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Figure 2 LOD scores from multipoint ASP analysis of 160 nuclear families. Microsatellite markers used in the original genome scan are
shown as unfilled triangles along the X axis. New microsatellite markers not included in the original scan are depicted as blackened triangles.
Solid lines represent results based on use of the narrow diagnosis, and dashed lines represent results based on use of the broad diagnosis.
The second-most-significant finding from the current
study derives from marker DXS1047 with an X-MLS
of 2.56 ( ). It is noteworthy that previousPp .0023
whole-genome scans have not detected evidence for loci
on the X chromosome that predispose to ASD, despite
several lines of evidence that suggest an X chromosomal
contribution. The most compelling evidence for sex-
related differences in susceptibility to autism comes
from the study of women with Turner syndrome (single
X chromosome). Creswell and Skuse (1999) recently
showed that 0 of 65 individuals with Turner syndrome
who harbored complete paternal X chromosomes de-
veloped autism, compared with 10 of 156 individuals
who had complete maternal X chromosomes. Further-
more, individuals in whom Turner syndrome is char-
acterized by cognitive defects are more likely to inherit
maternal X chromosomes than are individuals whose
cognitive function appears to be less impaired by Turner
syndrome (Skuse et al. 1997). These data led Skuse et
al. to propose that a gene related to social behavior
maps to the X chromosome and is subject to imprinting.
Furthermore, Gillberg (1989) noted that, although se-
verely disabled mentally retarded patients with ASD are
distributed at a 1:1 sex ratio, higher functioning pa-
tients with ASD exhibit a 10:1 male:female ratio.
In view of this evidence and our data suggesting
sex-specific parental contributions to IBD-sharing in
ASPs (table 1), we performed an additional analysis,
wherein we conditioned linkage data on maternal-
allele sharing at the DXS1047 locus. ASPs that share
predominantly maternal alleles at both D19S714 and
DXS1047 yield an MLS score of 3.59. Our data sug-
gest that a putative X chromosomal ASD locus might
function optimally in concert with other autosomal
loci, thereby providing a possible explanation for the
failure of previous linkage studies to identify ASD
susceptibility loci on the X chromosome.
In the present study, we have supplemented our sta-
tistical genetic analyses with the recently developed
scan-statistic method of human gene mapping (Hoh and
Ott 2000). The method exploits information contained
in marker loci that flank the marker with a given peak
LOD score (or other peak statistic). In the sib-pair data,
for chromosome 8 markers, the genomewide signifi-
cance level for a susceptibility locus at or near D8S1136
is , on a marker-by-marker basis. WhenP p .131global
flanking markers are taken into account through the
scan statistic, the corresponding significance level drops
to !5%, a value that is generally considered significant.
The scan statistic does not improve the localization of
susceptibility genes, but it tends to make results more
significant, that is, it improves power. The use of scan
statistics in the analysis of entire families provided
stronger significance for markers D5S2488 and
D8S1179 than was obtained with independent sib pairs.
It also confirmed the results for marker D19S714 ob-
tained with multipoint analysis.
A major concern in the mapping of complex trait loci
is how best to interpret evidence for linkage between
marker alleles and phenotype. In the Results section of
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this report, we refer to suggested thresholds for accep-
tance of genomewide suggestive and significant linkage;
however, these figures are known to be conservative, as
they assume complete (100%) marker informativeness
and an infinitely dense map. Although Lander andKrug-
lyak (1995) clearly state this, it is difficult to extend
their thresholds to real data sets. For example, although
they give estimates for how much the significant LOD
score threshold would decrease if map densities were
10 cM (∼20%), they mention that this decrease in
threshold would be appropriate only if one performed
two-point analyses. Measured according to the Marsh-
field map (Broman et al. 1998), the 335 markers used
in the present study span ∼4,400 cM and thus result in
an average map density of ∼13 cM. If we liberally apply
the proposed 10-cM decrease of 20% to the standard
(parametric) significant linkage threshold of LOD 1
( ), we generate a lower significant53.3 P ! 4.9# 10
linkage threshold of ( ). By4LOD 1 2.64 P ! 2.4# 10
the same reasoning, when we apply possible-triangle
thresholds, we generate MLS thresholds 12.91 and X
chromosome MLS thresholds 13.55. However, because
we report multipoint LOD scores with an average of
81% marker informativeness (calculated using the mul-
tipoint Infomap function in MAPMAKER/SIBS), it is
difficult to interpret our results according to the pro-
posed metrics.
To mitigate such difficulties in interpretation of the
linkage-analysis results, we used simulation to calculate
sample-specific empirical genomewide significance val-
ues for our data sets. Put simply, suggestive and signif-
icant linkages correspond to statistical evidence ex-
pected to occur (i.e., an OE) of 1 and 0.05 times by
chance per genome scan, respectively (Lander and Krug-
lyak 1995). The improvement observed in genomewide
significance was substantial, with loci on chromosomes
5, 19, and X reaching the accepted threshold for sug-
gestive linkage. If we strictly used the LOD score thresh-
olds of Lander and Kruglyak (1995), only the loci on
chromosomes 5 and 19 would reach these criteria. In-
stead, the simulation results produced genomewide val-
ues that were many times more significant; for example,
the chromosome 5 result is five times more significant,
and the chromosome 19 result is more than three times
more significant. As a result, we urge the use of caution
when interpreting genome-scan results in terms of
the strict genomewide significance values of Lander
and Kruglyak (1995) and, instead, strongly recommend
that simulations be used to interpret genomewide
significance.
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